BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

  November 6, 2024

   · 

  11 min read
• Press Releases

  Onc.AI Serial Imaging Response Score Outperforms Traditional Methods for Early Assessment of NSCLC Immunotherapy Outcomes

  November 6, 2024

   · 

  2 min read
• 

  CAR-T

  Gilead, Arcellx Tout Best-in-Class Potential for CAR T Therapy in Multiple Myeloma

  Truist Securities analyst Asthika Goonewardene in an investor note said data for anito-cel—particularly its safety profile—will help differentiate the CAR T therapy from Legend Biotech and J&J’s entrenched Carvykti in relapsed and refractory multiple myeloma.

  November 6, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  China

  AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud

  BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” to AstraZeneca, but contends that the share selloff is “overdone” and likely a knee-jerk reaction by investors.

  November 6, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Olema Oncology to Participate in Upcoming Investor Conferences

  November 6, 2024

   · 

  1 min read
• Press Releases

  Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

  November 6, 2024

   · 

  1 min read
• Press Releases

  Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024

  November 6, 2024

   · 

  1 min read
• Press Releases

  BioCryst to Present at Upcoming Investor Conferences

  November 6, 2024

   · 

  1 min read
• Press Releases

  Immunocore reports third quarter financial results and provides a business update

  November 6, 2024

   · 

  25 min read
• Press Releases

  Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

  November 6, 2024

   · 

  56 min read